Gabapentin Market Report

Global Gabapentin Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：226
  • REPORT CODE：GMM775677
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise. Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.

    Gabapentin market report explains the definition, types, applications, major countries, and major players of the Gabapentin market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Mylan

    • Alkem

    • Apotex

    • Aurobindo Pharma

    • Novartis

    • Amneal

    • Sailike

    • Marksans Pharma

    • Arbor Pharma

    • Jiangsu Enhua

    • TEVA

    • Sun Pharmaceutical

    • Jiangsu Hengrui

    • Assertio Therapeutics

    • Glenmark

    • Intas

    By Type:

    • Capsule

    • Tablet

    By End-User:

    • Epilepsy

    • Neuropathic Pain

    • Restless Legs Syndrome

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Gabapentin Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Gabapentin Outlook to 2028- Original Forecasts

    • 2.2 Gabapentin Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Gabapentin Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Gabapentin Market- Recent Developments

    • 6.1 Gabapentin Market News and Developments

    • 6.2 Gabapentin Market Deals Landscape

    7 Gabapentin Raw Materials and Cost Structure Analysis

    • 7.1 Gabapentin Key Raw Materials

    • 7.2 Gabapentin Price Trend of Key Raw Materials

    • 7.3 Gabapentin Key Suppliers of Raw Materials

    • 7.4 Gabapentin Market Concentration Rate of Raw Materials

    • 7.5 Gabapentin Cost Structure Analysis

      • 7.5.1 Gabapentin Raw Materials Analysis

      • 7.5.2 Gabapentin Labor Cost Analysis

      • 7.5.3 Gabapentin Manufacturing Expenses Analysis

    8 Global Gabapentin Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Gabapentin Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Gabapentin Export by Region (Top 10 Countries) (2017-2028)

    9 Global Gabapentin Market Outlook by Types and Applications to 2022

    • 9.1 Global Gabapentin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Capsule Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tablet Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gabapentin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Epilepsy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Neuropathic Pain Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Restless Legs Syndrome Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Gabapentin Market Analysis and Outlook till 2022

    • 10.1 Global Gabapentin Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Gabapentin Consumption (2017-2022)

      • 10.2.2 Canada Gabapentin Consumption (2017-2022)

      • 10.2.3 Mexico Gabapentin Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Gabapentin Consumption (2017-2022)

      • 10.3.2 UK Gabapentin Consumption (2017-2022)

      • 10.3.3 Spain Gabapentin Consumption (2017-2022)

      • 10.3.4 Belgium Gabapentin Consumption (2017-2022)

      • 10.3.5 France Gabapentin Consumption (2017-2022)

      • 10.3.6 Italy Gabapentin Consumption (2017-2022)

      • 10.3.7 Denmark Gabapentin Consumption (2017-2022)

      • 10.3.8 Finland Gabapentin Consumption (2017-2022)

      • 10.3.9 Norway Gabapentin Consumption (2017-2022)

      • 10.3.10 Sweden Gabapentin Consumption (2017-2022)

      • 10.3.11 Poland Gabapentin Consumption (2017-2022)

      • 10.3.12 Russia Gabapentin Consumption (2017-2022)

      • 10.3.13 Turkey Gabapentin Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Gabapentin Consumption (2017-2022)

      • 10.4.2 Japan Gabapentin Consumption (2017-2022)

      • 10.4.3 India Gabapentin Consumption (2017-2022)

      • 10.4.4 South Korea Gabapentin Consumption (2017-2022)

      • 10.4.5 Pakistan Gabapentin Consumption (2017-2022)

      • 10.4.6 Bangladesh Gabapentin Consumption (2017-2022)

      • 10.4.7 Indonesia Gabapentin Consumption (2017-2022)

      • 10.4.8 Thailand Gabapentin Consumption (2017-2022)

      • 10.4.9 Singapore Gabapentin Consumption (2017-2022)

      • 10.4.10 Malaysia Gabapentin Consumption (2017-2022)

      • 10.4.11 Philippines Gabapentin Consumption (2017-2022)

      • 10.4.12 Vietnam Gabapentin Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Gabapentin Consumption (2017-2022)

      • 10.5.2 Colombia Gabapentin Consumption (2017-2022)

      • 10.5.3 Chile Gabapentin Consumption (2017-2022)

      • 10.5.4 Argentina Gabapentin Consumption (2017-2022)

      • 10.5.5 Venezuela Gabapentin Consumption (2017-2022)

      • 10.5.6 Peru Gabapentin Consumption (2017-2022)

      • 10.5.7 Puerto Rico Gabapentin Consumption (2017-2022)

      • 10.5.8 Ecuador Gabapentin Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Gabapentin Consumption (2017-2022)

      • 10.6.2 Kuwait Gabapentin Consumption (2017-2022)

      • 10.6.3 Oman Gabapentin Consumption (2017-2022)

      • 10.6.4 Qatar Gabapentin Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Gabapentin Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Gabapentin Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Gabapentin Consumption (2017-2022)

      • 10.7.2 South Africa Gabapentin Consumption (2017-2022)

      • 10.7.3 Egypt Gabapentin Consumption (2017-2022)

      • 10.7.4 Algeria Gabapentin Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Gabapentin Consumption (2017-2022)

      • 10.8.2 New Zealand Gabapentin Consumption (2017-2022)

    11 Global Gabapentin Competitive Analysis

    • 11.1 Mylan

      • 11.1.1 Mylan Company Details

      • 11.1.2 Mylan Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Mylan Gabapentin Main Business and Markets Served

      • 11.1.4 Mylan Gabapentin Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Alkem

      • 11.2.1 Alkem Company Details

      • 11.2.2 Alkem Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Alkem Gabapentin Main Business and Markets Served

      • 11.2.4 Alkem Gabapentin Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Apotex

      • 11.3.1 Apotex Company Details

      • 11.3.2 Apotex Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Apotex Gabapentin Main Business and Markets Served

      • 11.3.4 Apotex Gabapentin Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Aurobindo Pharma

      • 11.4.1 Aurobindo Pharma Company Details

      • 11.4.2 Aurobindo Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Aurobindo Pharma Gabapentin Main Business and Markets Served

      • 11.4.4 Aurobindo Pharma Gabapentin Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Gabapentin Main Business and Markets Served

      • 11.5.4 Novartis Gabapentin Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Amneal

      • 11.6.1 Amneal Company Details

      • 11.6.2 Amneal Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Amneal Gabapentin Main Business and Markets Served

      • 11.6.4 Amneal Gabapentin Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sailike

      • 11.7.1 Sailike Company Details

      • 11.7.2 Sailike Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sailike Gabapentin Main Business and Markets Served

      • 11.7.4 Sailike Gabapentin Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Marksans Pharma

      • 11.8.1 Marksans Pharma Company Details

      • 11.8.2 Marksans Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Marksans Pharma Gabapentin Main Business and Markets Served

      • 11.8.4 Marksans Pharma Gabapentin Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Arbor Pharma

      • 11.9.1 Arbor Pharma Company Details

      • 11.9.2 Arbor Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Arbor Pharma Gabapentin Main Business and Markets Served

      • 11.9.4 Arbor Pharma Gabapentin Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Jiangsu Enhua

      • 11.10.1 Jiangsu Enhua Company Details

      • 11.10.2 Jiangsu Enhua Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Jiangsu Enhua Gabapentin Main Business and Markets Served

      • 11.10.4 Jiangsu Enhua Gabapentin Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 TEVA

      • 11.11.1 TEVA Company Details

      • 11.11.2 TEVA Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 TEVA Gabapentin Main Business and Markets Served

      • 11.11.4 TEVA Gabapentin Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Sun Pharmaceutical

      • 11.12.1 Sun Pharmaceutical Company Details

      • 11.12.2 Sun Pharmaceutical Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Sun Pharmaceutical Gabapentin Main Business and Markets Served

      • 11.12.4 Sun Pharmaceutical Gabapentin Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Jiangsu Hengrui

      • 11.13.1 Jiangsu Hengrui Company Details

      • 11.13.2 Jiangsu Hengrui Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Jiangsu Hengrui Gabapentin Main Business and Markets Served

      • 11.13.4 Jiangsu Hengrui Gabapentin Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Assertio Therapeutics

      • 11.14.1 Assertio Therapeutics Company Details

      • 11.14.2 Assertio Therapeutics Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Assertio Therapeutics Gabapentin Main Business and Markets Served

      • 11.14.4 Assertio Therapeutics Gabapentin Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Glenmark

      • 11.15.1 Glenmark Company Details

      • 11.15.2 Glenmark Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Glenmark Gabapentin Main Business and Markets Served

      • 11.15.4 Glenmark Gabapentin Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Intas

      • 11.16.1 Intas Company Details

      • 11.16.2 Intas Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Intas Gabapentin Main Business and Markets Served

      • 11.16.4 Intas Gabapentin Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    12 Global Gabapentin Market Outlook by Types and Applications to 2028

    • 12.1 Global Gabapentin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Capsule Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Tablet Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Gabapentin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Neuropathic Pain Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Restless Legs Syndrome Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Gabapentin Market Analysis and Outlook to 2028

    • 13.1 Global Gabapentin Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Gabapentin Consumption Forecast (2022-2028)

      • 13.2.2 Canada Gabapentin Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Gabapentin Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Gabapentin Consumption Forecast (2022-2028)

      • 13.3.2 UK Gabapentin Consumption Forecast (2022-2028)

      • 13.3.3 Spain Gabapentin Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Gabapentin Consumption Forecast (2022-2028)

      • 13.3.5 France Gabapentin Consumption Forecast (2022-2028)

      • 13.3.6 Italy Gabapentin Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Gabapentin Consumption Forecast (2022-2028)

      • 13.3.8 Finland Gabapentin Consumption Forecast (2022-2028)

      • 13.3.9 Norway Gabapentin Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Gabapentin Consumption Forecast (2022-2028)

      • 13.3.11 Poland Gabapentin Consumption Forecast (2022-2028)

      • 13.3.12 Russia Gabapentin Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Gabapentin Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Gabapentin Consumption Forecast (2022-2028)

      • 13.4.2 Japan Gabapentin Consumption Forecast (2022-2028)

      • 13.4.3 India Gabapentin Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Gabapentin Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Gabapentin Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Gabapentin Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Gabapentin Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Gabapentin Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Gabapentin Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Gabapentin Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Gabapentin Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Gabapentin Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Gabapentin Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Gabapentin Consumption Forecast (2022-2028)

      • 13.5.3 Chile Gabapentin Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Gabapentin Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Gabapentin Consumption Forecast (2022-2028)

      • 13.5.6 Peru Gabapentin Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Gabapentin Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Gabapentin Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Gabapentin Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Gabapentin Consumption Forecast (2022-2028)

      • 13.6.3 Oman Gabapentin Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Gabapentin Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Gabapentin Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Gabapentin Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Gabapentin Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Gabapentin Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Gabapentin Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Gabapentin Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Gabapentin Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Gabapentin Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Gabapentin

    • Figure of Gabapentin Picture

    • Table Global Gabapentin Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Gabapentin Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Capsule Consumption and Growth Rate (2017-2022)

    • Figure Global Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Neuropathic Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Restless Legs Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Gabapentin Consumption by Country (2017-2022)

    • Table North America Gabapentin Consumption by Country (2017-2022)

    • Figure United States Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Canada Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Mexico Gabapentin Consumption and Growth Rate (2017-2022)

    • Table Europe Gabapentin Consumption by Country (2017-2022)

    • Figure Germany Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure UK Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Spain Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Belgium Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure France Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Italy Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Denmark Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Finland Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Norway Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Sweden Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Poland Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Russia Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Turkey Gabapentin Consumption and Growth Rate (2017-2022)

    • Table APAC Gabapentin Consumption by Country (2017-2022)

    • Figure China Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Japan Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure India Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Thailand Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Singapore Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Philippines Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Gabapentin Consumption and Growth Rate (2017-2022)

    • Table South America Gabapentin Consumption by Country (2017-2022)

    • Figure Brazil Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Colombia Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Chile Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Argentina Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Peru Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Gabapentin Consumption and Growth Rate (2017-2022)

    • Table GCC Gabapentin Consumption by Country (2017-2022)

    • Figure Bahrain Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Oman Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Qatar Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Gabapentin Consumption and Growth Rate (2017-2022)

    • Table Africa Gabapentin Consumption by Country (2017-2022)

    • Figure Nigeria Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure South Africa Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Egypt Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure Algeria Gabapentin Consumption and Growth Rate (2017-2022)

    • Table Oceania Gabapentin Consumption by Country (2017-2022)

    • Figure Australia Gabapentin Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Gabapentin Consumption and Growth Rate (2017-2022)

    • Table Mylan Company Details

    • Table Mylan Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Gabapentin Main Business and Markets Served

    • Table Mylan Gabapentin Product Portfolio

    • Table Alkem Company Details

    • Table Alkem Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alkem Gabapentin Main Business and Markets Served

    • Table Alkem Gabapentin Product Portfolio

    • Table Apotex Company Details

    • Table Apotex Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Gabapentin Main Business and Markets Served

    • Table Apotex Gabapentin Product Portfolio

    • Table Aurobindo Pharma Company Details

    • Table Aurobindo Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Gabapentin Main Business and Markets Served

    • Table Aurobindo Pharma Gabapentin Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Gabapentin Main Business and Markets Served

    • Table Novartis Gabapentin Product Portfolio

    • Table Amneal Company Details

    • Table Amneal Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amneal Gabapentin Main Business and Markets Served

    • Table Amneal Gabapentin Product Portfolio

    • Table Sailike Company Details

    • Table Sailike Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sailike Gabapentin Main Business and Markets Served

    • Table Sailike Gabapentin Product Portfolio

    • Table Marksans Pharma Company Details

    • Table Marksans Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Marksans Pharma Gabapentin Main Business and Markets Served

    • Table Marksans Pharma Gabapentin Product Portfolio

    • Table Arbor Pharma Company Details

    • Table Arbor Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arbor Pharma Gabapentin Main Business and Markets Served

    • Table Arbor Pharma Gabapentin Product Portfolio

    • Table Jiangsu Enhua Company Details

    • Table Jiangsu Enhua Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Enhua Gabapentin Main Business and Markets Served

    • Table Jiangsu Enhua Gabapentin Product Portfolio

    • Table TEVA Company Details

    • Table TEVA Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEVA Gabapentin Main Business and Markets Served

    • Table TEVA Gabapentin Product Portfolio

    • Table Sun Pharmaceutical Company Details

    • Table Sun Pharmaceutical Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Gabapentin Main Business and Markets Served

    • Table Sun Pharmaceutical Gabapentin Product Portfolio

    • Table Jiangsu Hengrui Company Details

    • Table Jiangsu Hengrui Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Gabapentin Main Business and Markets Served

    • Table Jiangsu Hengrui Gabapentin Product Portfolio

    • Table Assertio Therapeutics Company Details

    • Table Assertio Therapeutics Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Assertio Therapeutics Gabapentin Main Business and Markets Served

    • Table Assertio Therapeutics Gabapentin Product Portfolio

    • Table Glenmark Company Details

    • Table Glenmark Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glenmark Gabapentin Main Business and Markets Served

    • Table Glenmark Gabapentin Product Portfolio

    • Table Intas Company Details

    • Table Intas Gabapentin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intas Gabapentin Main Business and Markets Served

    • Table Intas Gabapentin Product Portfolio

    • Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neuropathic Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Restless Legs Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gabapentin Consumption Forecast by Country (2022-2028)

    • Table North America Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure United States Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure Germany Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure China Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure Brazil Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Gabapentin Consumption Forecast by Country (2022-2028)

    • Figure Australia Gabapentin Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Gabapentin Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US